何鶴輝醫生 DR HO HOK FAI

何鶴輝醫生 DR HO HOK FAI

 

性別︰

專業資格︰

香港大學內外全科醫學士 1980
英國皇家內科醫學院院士 1987
香港內科醫學院院士 1992
香港醫學專科學院院士(內科) 1993
英國愛丁堡皇家內科醫學院榮授院士

 

註冊專科︰ 呼吸系統科

地址︰

銅鑼灣怡和街46-54號麥當勞大廈601

地區︰

銅鑼灣

執業類別︰

私人執業

語言或方言︰

廣東話, 英文

醫療服務項目︰

ECG
Bronchocopy
Chest Drain 
Check Tapping

在診所以外所提供的醫療服務項目:

 

使用醫院︰

 養和醫院, 聖保祿醫院 

辦公室電話︰

25763321

辦公室傳真︰

25769830

傳呼機 :

78966996

手提電話︰

 

電郵地址︰

[email protected]

 

 

溫志堅醫生 DR WAN Chi Kin

 

溫志堅醫生 DR WAN Chi Kin

 

性別︰

專業資格︰

香港中文大學內外全科醫學士 MBChB (CUHK) 2002
香港內科醫學院院士 FHKCP 2009
香港醫學專科學院院士(內科) FHKAM (Medicine) 2010

 

註冊專科︰ 呼吸系統科

地址︰

銅鑼灣東院道2號香港聖保祿醫院

地區︰

 

執業類別︰

私人執業

語言或方言︰

廣東話, 英文, 國語

醫療服務項目︰

 

在診所以外所提供的醫療服務項目:

 

醫療程序及手術︰

 

使用醫院︰

銅鑼灣聖保祿醫院

辦公室電話︰

28303709

辦公室傳真︰

 

傳呼機 :

78889020

手提電話

 

電郵地址︰

[email protected]

 

 

醫學節目主持Dr. Oz 被聯署要求革職

 美國著名醫學節目主持人奧茲,被一批醫生投訴為個人利益,推介欠科學根據的醫療產品,危害公眾健康,要求哥倫比亞大學醫學院革除他外科副主任職務。

奧茲擅長以輕鬆風趣手法,講解深奧醫學常識,收視一直高企;同時語出驚人,聲言一定不讓自己子女接種疫苗、伊波拉病毒可在空氣傳播等等,言論惹來醫學界抨擊。

十名醫學界人士、包括史丹福大學的專家聯署,要求哥倫比亞大學解除奧茲的醫學院外科副主任職務,批評奧茲為了金錢利益,不惜誤導觀眾,介紹欠科學根據的產品,漠視科學求真的精神。有加拿大研究指,奧茲推介的藥物和療程逾半欠科學根據。奧茲在去年更被傳召到國會問話。

這位土耳其裔的醫生,因是名嘴奧花雲費的門生而走紅,目前為奧花雲費的製作公司做節目。他反駁指自己只是盡量提供資訊予消費者,不涉利益。哥倫比亞大學發聲明,尊重教職員言論及學術自由。

 

cablenews.i-cable.com/webapps/news_video/index.php

 

————————————————–
 

Dr. Oz responds after prominent physicians call for his firing from Columbia University

 
 April 18 

You know Dr. Oz. He has a popular show where he dishes medical advice, some of which has earned him criticism. But he's not just a television host: Dr. Mehmet Oz is also a cardiothoracic surgeon who holds the surgery department vice chairmanship at Columbia University's medical school.

That Columbia affiliation doesn't sit well with some doctors, 10 of whom from various institutions sent a letter to Columbia's dean of medicine, Lee Goldman, calling for Oz's dismissal from the school. His position at "a prestigious medical institution," the doctors wrote, is "unacceptable."

[Researchers retract bogus, Dr. Oz-touted study on green coffee bean weight-loss pills]

"We are surprised and dismayed that Columbia University’s College of Physicians and Surgeons would permit Dr. Mehmet Oz to occupy a faculty appointment, let alone a senior administrative position in the Department of Surgery," reads the letter.

On Friday, Oz defended himself.

"I bring the public information that will help them on their path to be their best selves," Oz said in a statement, according to USA Today. The newspaper reported that the statement was released by a "Dr. Oz Show" representative. "We provide multiple points of view, including mine, which is offered without conflict of interest," the statement continued. "That doesn't sit well with certain agendas which distort the facts."

Oz has come under intense scrutiny — including a congressional grilling — for pitching questionable weight loss schemes and other medical guidance. As The Post's Abby Phillip wrote last year:

Oz has done a lot to damage his credibility as a medical doctor over the years. He came under fire for touting "miracle" weight-loss products that turned out to be entirely discredited; for announcing that his own children wouldn't be vaccinated(which he blamed on his wife's insistence); and for suggestingon national TV that the Ebola virus could become airborne.

In the letter to Columbia's Goldman, sent via e-mail this week by Dr. Henry I. Miller of Stanford University's Hoover Institution, the doctors refer to Oz warning his viewers about arsenic in certain apple juice brands and other stances he has taken.

[Half of Dr. Oz’s medical advice is baseless or wrong, study says]

"Dr. Oz has repeatedly shown disdain for science and for evidence-based medicine, as well as baseless and relentless opposition to the genetic engineering of food crops," the letter states. "Worst of all, he has manifested an egregious lack of integrity by promoting quack treatments and cures in the interest of personal financial gain."

 

Representatives from "The Dr. Oz Show" initially referred The Post to Columbia's office of communications.

Columbia University Medical Center spokesman Doug Levy wrote in a response to Miller and the others: "As I am sure you understand and appreciate, Columbia is committed to the principle of academic freedom and to upholding faculty members' freedom of expression for statements they make in public discussion."

Miller responded to Levy that "freedoms end where patient safety begins, and Oz's promotion of worthless products that might have side effects and that delay patients' seeking safe and effective therapies threatens public safety."

Oz is also a Columbia University professor of surgery and directs the New York-Presbyterian Hospital's Cardiovascular Institute and Complementary Medicine Program.

[Dr. Oz solicits health questions on Twitter, gets attacked by trolls instead]

The physicians' letter to Columbia also took issue with Oz's "baseless and relentless opposition to the genetic engineering of food crops."

In his statement, USA Today reported, Oz responded:

"I do not claim that GMO foods are dangerous, but believe that they should be labeled like they are in most countries around the world."

He added: "I will address this on the show next week."

Here is the whole text of the letter. Two additional New York doctors also wanted to sign after the letter was sent, Miller said:

Lee Goldman, M.D.
Dean of the Faculties of Health Sciences and Medicine
Columbia University

Dear Dr. Goldman:

I am writing to you on behalf of myself and the undersigned colleagues below, all of whom are distinguished physicians.

We are surprised and dismayed that Columbia University's College of Physicians and Surgeons would permit Dr. Mehmet Oz to occupy a faculty appointment, let alone a senior administrative position in the Department of Surgery.

As described here and here, as well as in other publications, Dr. Oz has repeatedly shown disdain for science and for evidence-based medicine, as well as baseless and relentless opposition to the genetic engineering of food crops. Worst of all, he has manifested an egregious lack of integrity by promoting quack treatments and cures in the interest of personal financial gain.

Thus, Dr. Oz is guilty of either outrageous conflicts of interest or flawed judgments [sic] about what constitutes appropriate medical treatments, or both. Whatever the nature of his pathology, members of the public are being misled and endangered, which makes Dr. Oz's presence on the faculty of a prestigious medical institution unacceptable.

Sincerely yours,

Henry I. Miller, M.D.
Robert Wesson Fellow in Scientific Philosophy
& Public Policy
Hoover Institution
Stanford University
Stanford, CA

Scott W. Atlas, M.D.
David and Joan Traitel Senior Fellow
Hoover Institution
Stanford University
Stanford, CA

Jack Fisher, M.D.
Professor of Surgery (emeritus)
University of California, San Diego
La Jolla, CA

Shelley Fleet, M.D.
Anesthesiologist
Longwood, FL

Gordon N. Gill, M.D.
Dean (emeritus) of Translational Medicine
University of California, San Diego
La Jolla, CA

Michael H. Mellon, M.D.
Pediatric Allergist
San Diego, CA

GIlbert Ross, M.D.
President (Acting) and Executive Director
American Council on Science and Health
New York, NY

Samuel Schneider, M.D.
Psychiatrist
Princeton, NJ

Glenn Swogger Jr. M.D.
Director of the Will Menninger Center for Applied Behavioral Sciences (retired)
The Menninger Foundation
Topeka, KS

Joel E. Tepper, M.D.
Hector MacLean Distinguished Professor of Cancer Research
Dept of Radiation Oncology
University of North Carolina School of Medicine
Chapel Hill, NC

[This post, originally published on April 16, has been updated.]

 

Elahe Izadi is a general assignment national reporter for The Washington Post.
 
www.washingtonpost.com/news/to-your-health/wp/2015/04/16/a-bunch-of-doctors-ask-columbia-university-to-cut-its-ties-with-dr-oz/

 

手機能幫助診斷癌症

 

美國麻省總醫院(MGH)研究人員開發出一種新的診斷平台,能利用智能手機對腫瘤及其他疾病做出快速、精確的分子診斷,為缺乏先進醫療技術的地區帶來好處。相關論文發表在美國《國家科學院院刊》上.

該平台稱為數字衍射診斷系統(D3),它將一個拍攝組件裝在標準智能手機上,通過全息攝影記錄下高分辨率圖像數據,並將這些數據上傳,經安全、加密的雲端服務器對圖形數據處理分析,然後把結果迅速返回醫療點。D3系統視野比傳統顯微鏡更大,能記錄血液或組織樣本中超過10萬個細胞的數據。

癌症造成的全球負擔,在許多地區限制人們得到病理檢查服務。新興的細胞剖面技術增加了對低成本、便攜式快速診斷方法的需求。”論文合著者、MGH癌症中心與系統生物學中心醫學博士塞薩爾·卡斯特羅說,他們開發的這一平台能以極低成本提供診斷所需的基本特征。

據物理學家組織網13日報道,D3系統的分析原理是,用結合了已知癌相關分子的微珠給血液或組織樣本作標記,拍攝圖像上傳到服務器後,通過分析微珠生成的衍射圖案,探測是否存在特殊分子。微珠的大小、塗層各不相同,能生成獨特的特征標識,D3平台的數字算法能區分細胞和微珠,分析10兆數據用時不到1/900秒。

在對癌細胞的試驗中,研究人員對25名婦女的宮頸活檢樣本進行了分析,D3系統能迅速可靠地把樣本分為高風險、低風險或良性三類;對於細針淋巴腺活檢樣本分析,能精確區分4種病人。結果均被傳統的病理檢查證實。結合蛋白質分析,系統還能靈敏地探測DNA,如人類乳頭狀瘤病毒等。在這些測試中,可在1小時內得到化驗結果,每次只需1.8美元,今後價格還會進一步下降。

“我們期望D3平台能增加癌症篩查的廣度和深度,在資源有限的環境下切實可行,讓人們能負擔得起。”論文高級作者、MGH系統生物學中心主管拉爾夫·維斯萊德說,手機技術在全球日益普及,利用這種優勢,我們的系統能幫助選擇治療方案,減少因病理檢查缺乏而導致的延誤,減少病人定期覆查的需求。
另一名論文高級作者海克·李指出,這一技術未來發展重在三個方面:一是研究D3平台分析其他疾病媒介的蛋白質和DNA標記的能力,包括傳染性病原體和過敏原;二是將軟件與更大的數據庫結合;三是在發展中國家或農村醫療站點指導臨床研究,通過遠程信息共享實現家庭檢查。MGH已經提出了涵蓋D3技術在內的專利申請.

———————————————————————————————–

Cancer BREAKTHROUGH: Smartphone accessory can diagnose disease in less than an hour

A CUTTING-EDGE smartphone accessory could a provide fast and low-cost new way of diagnosing cancer.

 

Data recorded by the smartphone-powered device is then sent for processing in the cloud GETTY•PICTURES POSED BY MODELS

Data recorded by the smartphone-powered device is then sent for processing in the cloud

The device – dubbed a D3 system – includes a battery-powered LED light that allows a standard smartphone to record high-resolution imaging data with its camera.

We expect that the D3 platform will enhance the breadth and depth of cancer screening

Dr Ralph Weissleder

The D3 system, which stands for digital diffraction diagnosis, is capable of recording data on more than 100,000 cells from a blood or tissue sample in a single image. 

Data recorded by the smartphone-powered device is then sent for processing via a secure and encrypted cloud service.

In a pilot scheme for the new system, a correct diagnosis was returned from the cloud servers in less than an hour.

Researchers behind the new system claim the diagnosis costs just £1.25per sample – and will decrease over time.

Study co-lead author Doctor Cesar Castro, of the Massachusetts General Hospital Cancer Center in the United States, said: "The global burden of cancer, limited access to prompt pathology services in many regions and emerging cell profiling technologies increase the need for low-cost, portable and rapid diagnostic approaches that can be delivered at the point of care.

Samples captured and analysed by the pilot D3 systemNATIONAL NEWS

Samples captured and analysed by the pilot D3 system

"The emerging genomic and biological data for various cancers, which can be essential to choosing the most appropriate therapy, supports the need for molecular profiling strategies that are more accessible to providers, clinical investigators and patients; and we believe the platform we have developed provides essential features at an extraordinary low cost." 

Researchers say the D3 system employs the same technology that is used to make holograms to collect detailed microscopic images for digital analysis of the molecular composition of cells and tissues.

Investigators conducted analysis of cervical biopsy samples from 25 women with abnormal PAP smears.

The D3 analysis correctly categorised biopsy samples as high-risk, low-risk or benign – with each of the results matching those returned by conventional pathologic analysis.

Co-senior author Dr Ralph Weissleder said: "We expect that the D3 platform will enhance the breadth and depth of cancer screening in a way that is feasible and sustainable for resource limited-settings.

"By taking advantage of the increased penetration of mobile phone technology worldwide, the system should allow the prompt triaging of suspicious or high-risk cases that could help to offset delays caused by limited pathology services in those regions and reduce the need for patients to return for follow-up care, which is often challenging for them." 

 

www.express.co.uk/life-style/science-technology/570276/D3-System-Cancer-Smartphone-Accessory-Diagnose-Disease-Hour

 

馬桂宜及研究團隊發現幹細胞CD133為肝癌的重要功能記號

 

 

■馬桂宜及研究團隊發現幹細胞CD133為肝癌的重要功能記號。李穎宜 攝

香港文匯報訊(記者 李穎宜)肝癌是香港第三號癌症殺手,死亡率高達七成。現時的治療方法在於為患者進行化療或靶向治療,但仍有擴散及抗藥性的風險。為了更針對性尋找合適的標靶藥物及減低抗藥性,港大李嘉誠醫學院解剖學系助理教授馬桂宜,與團隊着力研究肝癌幹細胞CD133,發現該細胞為重要的癌病變記號,藉此闡明多個主要的信號傳遞路徑。該突破性發現,令馬桂宜成為2014年度「裘槎前瞻科研大獎」得主,並在昨日獲頒獎項。

祖父母癌逝 馬桂宜立志攻克

70後年輕學者馬桂宜的祖父母,均是因癌病病逝,故她立志要攻克癌症,期望藉着研究找出癌症機理,幫助病人接受針對性治療。她指出,癌症幹細胞跟普通幹細胞都有共同特徵,包括自我更新及分化能力。「癌症幹細胞猶如根部,要完全殺滅才能令癌症痊癒,否則癌症幹細胞會支配癌症,使其加速惡發。」

CD133比例愈高 存活率低

馬桂宜於2005年開始研究肝癌的機理,10年間,她及研究團隊發現了肝癌幹細胞CD133是重要的癌病變記號。若體內出現不受控信號通道,會使癌細胞不斷生長,亦會令其抗藥性變強,到時連化療都會失去作用。

馬桂宜的研究結果,適用於測檢患肝癌病人的復發機會和抗藥性的高低。研究過程中,馬桂宜發現100個肝癌病人中,有九成人體內都找到CD133的存在,各人被驗出的CD133成份各異,由1%至30%不等。數據顯示,CD133的比例愈高,病人的存活率就偏低。

提到研究過程的困難與挑戰,馬桂宜指研究要爭分奪秒,「我們需要配合醫護人員,於病人手術過程中抽取肝組織,為免組織受到污染及未能生長,研究要隨即進行。」她表示,有時要晚上七八時才開始研究,做到半夜,甚至通宵達旦去完成。

對於獲得「裘槎前瞻科研大獎」,5年獲得500萬元的研究經費。馬桂宜表示,團隊未來可以作出大膽嘗試,不用擔心資金短絀的問題,故稍後會擴展現時的八人團隊,亦會特別於美國訂購基因改造的老鼠,方便日後的研究。若有進一步的研究成果,會考慮申請專利及與藥廠合作,但她坦言,現時屬於基礎醫療研究,預計最少10年才可研究出針對性的藥物。

 

paper.wenweipo.com/2015/04/15/ED1504150003.htm

肝酵素

 (網络圖片)

「病人,你最近的驗血報告出了,肝酵素偏高呀。」

酵素,又稱酶,是人體內不可缺少的催化劑,無論在新陳代謝、消化、修復組織等方面我們均需要酵素,否則便不能滿足我們對能量的需求。肝酵素,顧名思義,就是在肝臟內的酵素,主要分為谷丙轉氨酶(ALT)及谷草轉氨酶(AST)兩種。不少人也知道它是用來量度肝臟健康的指數,然而,既然在前文說酵素是催化劑,那麼指數不是越高越好嗎?

其實事實並非如此,肝酵素升高的成因可能是因為肝臟受損或發炎,使在正常情況下藏在肝臟裡的酵素經受損部份釋放至血裡,量度血液中的肝酵素含量便可大概估計出肝臟的健康情況。而在肝酵素升高的情況下,我們可能也會計算AST對ALT的比例(AST/ALT ratio),從而更確定診斷。例如當比例少於一時,這可能是病毒性肝炎,其中一個例子就是聞名的乙型肝炎;比例大於二時則表示酒精性肝炎或肝癌。

可是,肝酵素回復正常時並不代表肝臟健康已康復。肝炎亦分為慢性或急性,當慢性肝炎病情穩定時,肝酵素的指數可能顯示正常,但病情轉變是不預測的,所以每次覆診時大多需要驗血,以監察病情進展。

此外,香港中文大學醫學院早年進行了研究,發現非酒精性脂肪肝患者和乙型肝炎患者的ALT值即使屬於正常水平,患上肝纖維化的風險仍然較一般人高。這說明了即使肝病患者的肝酵素回復正常亦並非代表肝臟健康已完全康復。

早前亦有聽說過一乙肝患者因服用了一些中藥成份的補肝產品,影響了肝酵素值,令患者誤以為康復,延誤了診治而使病情更嚴重的個案。雖然當中有很多細節需有待了解,但可以肯定,補肝必須謹慎,尤其服用中藥成份的補肝產品時,必須格外小心。例如雲芝、靈芝產品有可能會說明對癌症病人化療、電療或接受手術前後,都有保護和改善作用。但這些產品均有機會使肝酵素提高,增加病人的肝臟負擔,必須多加注意。

所以,最好的辦法就是先資詢醫生或藥劑師的意見才服用,以免補肝不成,反而加重肝臟負擔,補肝變成傷肝。

www.derchk.org/

乙肝病毒有機會引起肝纖維化甚至肝硬化 | 施迅鋒醫生

乙肝病毒有機會引起肝纖維化甚至肝硬化 | 施迅鋒醫生

 

乙肝病毒有機會引起肝纖維化甚至肝硬化 | 施迅鋒醫生

周偉昌醫生 DR CHOW WAI CHEONG

 

周偉昌醫生 DR CHOW WAI CHEONG

 

性別︰

專業資格︰

香港中文大學內外全科醫學士 
香港醫學專科學院院士(內科) 
愛爾蘭皇家醫學院兒科文憑 
英國格拉斯哥皇家醫學院兒科文憑 
英國皇家內科醫學院院士 
香港內科醫學院院士

 

註冊專科︰ 呼吸系統科

地址︰

荃灣荃景圍199號荃灣港安醫院

地區︰

荃灣

執業類別︰

私人執業

語言或方言︰

廣東話, 英文

醫療服務項目︰

 

在診所以外所提供的醫療服務項目:

 

使用醫院︰

荃灣港安醫院

辦公室電話︰

2276 7888

辦公室傳真︰

2275 6767

傳呼機 :

 

手提電話︰

 

電郵地址︰

[email protected]

 


盧志偉醫生 DR LO CHI WAI

盧志偉醫生 DR LO CHI WAI

23822276

性別︰
專業資格︰ 香港大學內外全科醫學士 1998
英國皇家內科醫學院院士 2001
香港內科醫學院院士 2008
香港醫學專科學院院士(內科) 2008
  註冊專科︰ 呼吸系統科
地址︰ 九龍佐敦彌敦道238號18樓
地區︰ 油尖旺
執業類別︰ 私人執業
語言或方言︰ 廣東話, 英文
醫療服務項目︰ 胸肺X
心電圖
肺功能檢查
長期咳嗽,氣管敏感診斷及治療
睡眠窒息症評估
支氣管內窺鏡檢查
胸腔導管引流法
胸腔液及肺膜組織抽取
使用醫院︰ 香港浸信會醫院 聖德肋撒醫院
播道醫院 荃灣港安醫院
仁安醫院 養和醫院 聖保祿醫院
辦公室電話︰ 26180266